2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Prophylaxis: new trials by email Literature Review of Prophylaxis trials Research Report on Prophylaxis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabotegravir-Hormone PK/PD Interactions for HIV Prevention Cabotegravir Injectable Suspension (CAB LA) - HIV, Prophylaxis | Phase 1 | Recruiting | Johns Hopkins University | 32 | 2026-07-07 | 2026-07-13 |
| Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW Truvada alone, Truvada plus Leuprolide 11.25mg intramuscular injection, Truvada plus Estradiol 1 mg - HIV, Prophylaxis | Phase 1 | Completed | Johns Hopkins University | 13 | 2021-03-01 | 2026-04-06 |
| Mesenchymal Stem Cells for the Treatment of COVID-19 PrimePro, Placebo - Covid19, Prophylaxis | Phase 1 | Completed | Thomas Advanced Medical LLC | 40 | 2020-04-24 | 2020-10-05 |
COVID-19 (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Emtricitabine (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Estradiol (1) · Estrogens (1) · Injections, Intramuscular (1) · Leuprolide (1) · Single Person (1) · Tenofovir (1) · cabotegravir (1)
Johns Hopkins University (2) · Thomas Advanced Medical LLC (1)
United States (3)
Ernst R Von Schwarz, MD, PhD (1) · Mark A Marzinke (1) · Mark A Marzinke, PhD (1)
R01AI145675 (1), R01AI186440 (1)